Serum nesfatin in overweight and obese children
https://doi.org/10.14341/omet12075
Abstract
BACKGROUND: Obesity is one of the most common children diseases. In present time it is being actively studied the natural hormones role in the pathogenesis of obesity.
AIMS: To determine the relationship between serum nesfatin level with impaired lipid metabolism in school age children with overweight and obesity.
MATERIALS AND METHODS: The study included children with overweight and obesity («case») and healthy children with normal body mass («control») aged 9 to 15 years. All children were determined by concentration in cholesterol blood and its factions, apoA-1, apoB. Enzyme-linked immunosorbent assay (Bio Human Nesfatin Enzyme Immunoassay Kit).
RESULTS: Groups of patients with overweight and obesity (n = 53) and healthy children (n = 31) were comparable by age and sex. In obese children, a significant decrease in the level of nesfatin-1 was revealed compared with the group with normal body weight. In cases of children obesity there is a marked decrease in the concentration of nesfatin-1 in serum, especially expressed in the dyslipidemia presence. The nesfatin-1 level are negatively correlated to BMI and body fat content.
CONCLUSIONS: The obtained data suggest that along with the known key role of nesfatin in the regulation of eating behavior and appetite, it also affects anthropometric indicators, primarily associated with the accumulation of excess fat mass. Based on the data obtained, nesfatin-1 should be considered as a possible marker for the development of obesity in children.
About the Authors
Vladimir V. Bazarnyi
Ural State Medical University
Russian Federation
Russian Federation
MD, PhD, Professor
Elena V. Anufrieva
Ural State Medical University
Russian Federation
Russian Federation
MD, PhD
Arina Yu. Maksimova
Ural State Medical University
Russian Federation
Russian Federation
Larisa G. Polushina
Ural State Medical University
Russian Federation
Russian Federation
MD, PhD
Olga P. Kovtun
Ural State Medical University
Russian Federation
Russian Federation
MD, PhD, Professor
References
1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-2642. DOI:10.1016/S0140-6736(17)32129-3
2. Федеральные клинические рекомендации (протоколы) по ведению детей с эндокринными заболеваниями. / Под ред. Дедова И.И., Петерковой В.А. — М.: Практика; 2014. [Dedov II, Peterkova VA, editors. Federal’nyye klinicheskiye rekomendatsii (protokoly) povedeniy u detey s endokrinnymi zabolevaniyami. Moscow: Praktika; 2014. (In Russ.)]
3. Российская ассоциация эндокринологов, Российское общество по профилактике неинфекционных заболеваний, Ассоциация детских кардиологов России. Рекомендации по диагностике, лечению и профилактике ожирения у детей и подростков. — М.: Практика; 2015. [Rossiyskaya assotsiatsiya endokrinologov, Rossiyskoe obshchestvo po profilaktike neinfektsionnykh zabolevaniy, Assotsiatsiya detskikh kardiologov Rossii. Rekomendatsii po diagnostike, lecheniyu i profilaktike ozhireniya u detey i podrostkov. Moscow: Praktika; 2015. (In Russ.)]
4. КарпушкинаА.В., Панкратова М.С. Стратегия профилактики ожирения среди детей школьного возраста (обзор литературы). // Проблемы эндокринологии.— 2016. — Т. 62. — №2. — С. 52-60. [Karpushkina AV, Pankratova MS. Strategy for obesity prevention among school-age children (literature review) Problems of endocrinology. 2016;62(2):52-60. (In Russ.)] DOI:10.14341/probl201662252-60
5. Алимова И.Л. Перспективы применения в педиатрической практике Федеральных клинических рекомендаций «Диагностика и лечение ожирения у детей и подростков». // Российский вестник перинатологии и педиатрии.— 2015. — Т. 60. — №1. — С. 66-70. [Alimova IL. Prospects for using the Federal Clinical Guidelines for the Diagnosis and Treatment of Obesity in Children and Adolescents in pediatric practice. Rossiiskii vestnik perinatologii i pediatrii. 2015;60(1):66-70. (In Russ.)]
6. Мартынова И.Н., Винярская И.В. Оптимизация лечебно-профилактической помощи детям с ожирением в условиях детской поликлиники. // Российский педиатрический журнал. — 2017. — Т. 20. — №5. — С. 276-282. [Martynova IN, Vinyarskaya IV. Development and evaluation of the effectiveness of the health school for children with obesity under the conditions of the child polyclinic. Russian journal of pediatrics. 2017;20(5):276-282. (In Russ.)] DOI:10.18821/1560-9561-2017-20(5)-276-282
7. Нетребенко О.К., Украинцев С.Е., Мельникова И.Ю. Ожирение у детей: новые концепции и направления профилактики. Обзор литературы. // Вопросы современной педиатрии. — 2017. — Т. 16. — №5. — С. 399-405. [Netrebenko OK, Ukraintsev SE, Melnikova IY. Ozhireniye u detey: novyye kontseptsii i napravleniya profilaktiki. Obzor literatury. Voprosy sovremennoy pediatrii. 2017;16(5):399-405. (In Russ.)] DOI:10.15690/vsp.v16i5.1804
8. Логвинова О.В., Пойдашева А.Г., Бакулин И.С., и др. Современные представления о патогенезе ожирения и новых подходах к его коррекции. // Ожирение и метаболизм. — 2018. — Т. 15. — №2. — С. 11-16. [Logvinova OV, Poydasheva AG, Bakulin IS, et al. Modern concepts of the pathogenesis of obesity and new approaches to its correction. Obesity and metabolism. 2018;15(2):11-16. (In Russ.)] DOI:10.14341/OMET9491
9. Howick K, Griffin BT, Cryan JF, Schellekens H. From Belly to Brain: Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation. Int J Mol Sci. 2017;18(2). DOI:10.3390/ijms18020273
10. Anik A, Catli G, Abaci A, et al. Fasting and postprandial levels of a novel anorexigenic peptide nesfatin in childhood obesity. J PediatrEndocrinolMetab. 2014;27(7-8):623-628. DOI:10.1515/jpem-2013-0475
11. Ayada C, Toru Ü, Korkut Y. Nesfatin-1 and its effects on different systems. Hippokratia. 2015;19(1):4-10.
12. Kim SH, Ahn MB, Cho WK, et al. The relation of serum nesfatin-1 level with anthropometric and metabolic parameters in children and adolescents: A prospective observational study. Medicine (Baltimore). 2019;98(19):e15460. DOI:10.1097/MD.0000000000015460
13. Kuyumcu A, Kuyumcu MS, Ozbay MB, et al. Nesfatin-1: A novel regulatory peptide associated with acute myocardial infarction and Mediterranean diet. Peptides. 2019;114:10-16. DOI:10.1016/j.peptides.2019.04.003
14. Schalla MA, Stengel A. Current Understanding of the Role of Nesfatin-1. J Endocr Soc. 2018;2(10):1188-1206. DOI:10.1210/js.2018-00246
15. Who.int [Internet]. Growth reference 5-19 years.BMI-for age (5-19years) [cited 2019 May 15]. Available from: https://www.who.int/growthref/who2007_bmi_for_age/en//.
16. Ковтун О.П., Ануфриева Е.В., Неупокоева Л.Ю. Особенности компонентного состава тела у детей и подростков с избыточной массой и ожирением. // Уральский медицинский журнал. — 2019. — №6. — С.104-109. [Kovtun OP, Anufrieva EV, Neupokoeva LY. Body component composition features of children with overweight and obesity. Ural’skiy meditsinskiy zhurnal. 2019;(6):104-109. (In Russ.)] DOI:10.25694/URMJ.2019.06.36
17. Dore R, Levata L, Lehnert H, Schulz C. Nesfatin-1: functions and physiology of a novel regulatory peptide. J Endocrinol. 2017;232(1):R45-R65. DOI:10.1530/JOE-16-0361
18. Oh IS, Shimizu H, Satoh T, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006;443(7112):709-712. DOI:10.1038/nature05162
19. Khalili S, Shekari Khaniani M, Afkhami F, Mansoori Derakhshan S. NUCB2/Nesfatin-1: A Potent Meal Regulatory Hormone and its Role in Diabetes. Egyptian Journal of Medical Human Genetics. 2017;18(2):105-109. DOI:10.1016/j.ejmhg.2016.10.003
20. Stengel A, Taché Y. Role of Brain NUCB2/nesfatin-1 in the Regulation of Food Intake. Curr Pharm Des. 2013;19(39):6955-6959. DOI:10.2174/138161281939131127125735
21. Abaci A, Catli G, Anik A, et al. The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children. PediatrDiabetes. 2013;14(3):189-195. DOI:10.1111/pedi.12009
22. Finelli C, Rossano R, Padula MC, et al. Nesfatin Role as Possible New Anti Obesity Treatment. J Obes Weight Loss Ther. 2014;04(03). DOI:10.4172/2165-7904.1000228
23. Schalla MA, Unniappan S, Lambrecht NWG, et al. NUCB2/nesfatin-1 - Inhibitory effects on food intake, body weight and metabolism. Peptides. 2020;128:170308. DOI:10.1016/j.peptides.2020.170308
24. Ramesh N, Gawli K, Pasupulleti VK, Unniappan S. Metabolic and Cardiovascular Actions of Nesfatin-1: Implications in Health and Disease. Curr Pharm Des. 2017;23(10):1453-1464. DOI:10.2174/1381612823666170130154407
25. Герасимчук О.А., Гирш Я.В. Композиционный состав тела у детей и подростков с ожирением. // Трансляционная медицина. — 2019. — Т. 6. — №1. — С. 51-57. [Gerasimchik OA, Girsh YaV. Compositional composition of the bode in obese children and adolescents. TranslationalMedicine. 2019;6(1):51-57. (In Russ.)] DOI:10.18705/2311-4495-2019-6-1-51-57
26. Ковалева О.Н., Ащеулова Т.В., Иванченко С.В., Гончарь А.В. Несфатин-1 и особенности липидного профиля у больных гипертонической болезнью, ассоциированной с ожирением и избыточной массой тела. // Научные ведомости Белгородского государственного университета. Серия: Медицина. Фармация. — 2016. — №26. — С.44-47. [Kovalyova ON, Ashcheulova TV, Ivanchenko SV, Gonchar AV. Nesfatin-1 and lipid profile peculiarities in hypertensive patients with obesity and overweight. Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta. Seriya: Meditsina. Farmatsiya. 2016;(26):44-47. (In Russ.)]
27. Weibert E, Hofmann T, Stengel A. Role of nesfatin-1 in anxiety, depression and the response to stress. Psychoneuroendocrinology. 2019;100:58-66. DOI:10.1016/j.psyneuen.2018.09.037
28. Imbrogno S, Angelone T, Cerra MC. Nesfatin-1 and the Cardiovascular System: Central and Pheripheral Actions and Cardioprotection. CurrDrugTargets. 2015;16(8):877-883. DOI:10.2174/1389450116666150408101431
29. Tekin T, Cicek B, Konyaligil N. Regulatory Peptide Nesfatin-1 and its Relationship with Metabolic Syndrome. Eurasian J Med. 2019;51(3):280-284. DOI:10.5152/eurasianjmed.2019.18420
30. Петеркова В.А., Таранушенко Т.Е., Киселева Н.Г., и др. Оценка показателей физического развития в детском возрасте. // Медицинский совет. — 2016. — №7. — С. 28-35. [Peterkova VA, Taranushenko TE, Kiseleva NG., et al. Evaluation of child growth status. Medical Council. 2016;(7):28-35. (In Russ.)] DOI:10.21518/2079-701X-2016-07-28-35
31. Руднев С.Г., Соболева Н.П., Стерликов С.А., Николаев Д.В. Биоимпедансное исследование состава тела населения России. — М.: РИО ЦНИИОИЗ; 2014. [Rudnev SG, Soboleva NP, Sterlikov SA, Nikolaev DV. Bioimpedansnoye issledovaniye sostava tela naseleniya Rossii. Moscow: RIO TSNIIOIZ; 2014. (In Russ.)]
Supplementary files
Review
For citations:
Bazarnyi V.V., Anufrieva E.V., Maksimova A.Yu., Polushina L.G., Kovtun O.P. Serum nesfatin in overweight and obese children. Obesity and metabolism. 2020;17(2):200-207. (In Russ.) https://doi.org/10.14341/omet12075
Views:
1144
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
